Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy

Background/Purpose: We sought to compare the diagnostic performances of 68Ga-PSMA-11 PET/CT and prostate/whole-abdomen multiparametric magnetic resonance imaging (PWAmpMRI) in Taiwanese patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. Methods: Bet...

Full description

Bibliographic Details
Main Authors: Jing-Ren Tseng, Kai-Jie Yu, Feng-Yuan Liu, Lan-Yan Yang, Ji-Hong Hong, Tzu-Chen Yen, See-Tong Pang, Li-Jen Wang
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Journal of the Formosan Medical Association
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664620303417
_version_ 1818603522481979392
author Jing-Ren Tseng
Kai-Jie Yu
Feng-Yuan Liu
Lan-Yan Yang
Ji-Hong Hong
Tzu-Chen Yen
See-Tong Pang
Li-Jen Wang
author_facet Jing-Ren Tseng
Kai-Jie Yu
Feng-Yuan Liu
Lan-Yan Yang
Ji-Hong Hong
Tzu-Chen Yen
See-Tong Pang
Li-Jen Wang
author_sort Jing-Ren Tseng
collection DOAJ
description Background/Purpose: We sought to compare the diagnostic performances of 68Ga-PSMA-11 PET/CT and prostate/whole-abdomen multiparametric magnetic resonance imaging (PWAmpMRI) in Taiwanese patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. Methods: Between June 2017 and December 2018, we prospectively enrolled 34 patients. Upon review of all available clinical and imaging data, a best valuable comparator (BVC) was defined on an individual basis in the light of a consensus reached by a multidisciplinary tumor board. Diagnostic positivity was investigated in relation to the different lesion types. Results: On a patient-based analysis, 68Ga-PSMA-11 PET/CT and PWAmpMRI showed a moderate agreement (kappa coefficient = 0.62). 68Ga-PSMA-11 PET/CT identified local recurrences, regional, and non-regional lymph node metastases, and bone metastases in 15, 10, 1, and 5 patients, respectively. Conversely, PWAmpMRI detected these lesions in 26, 8, 1, and 4 patients, respectively. When the BVC was used as reference standard, the positive diagnostic rates for local recurrences, regional lymph node metastases, non-regional lymph node metastases, and bone metastases were 57.7%, 90.9%, 100%, and 100%, respectively for 68Ga-PSMA-11 PET/CT, and 100%, 72.7%, 100%, and 80% for PWAmpMRI, respectively. The use of both PWAmpMRI and 68Ga-PSMA-11 PET/CT showed a complete diagnostic yield for detecting both local recurrence and systemic failure when PSA levels reached 0.5 ng/mL. Conclusion: Due to urine radioactivity, 68Ga-PSMA-11 PET/CT performs less than PWAmpMRI on local recurrences. However, it can have a complementary diagnostic role in the detection of lymph node metastases and in identifying non-axial bone metastases beyond the PWAmpMRI scanning field.
first_indexed 2024-12-16T13:24:31Z
format Article
id doaj.art-927c808bd39d4637a520827fe49a0707
institution Directory Open Access Journal
issn 0929-6646
language English
last_indexed 2024-12-16T13:24:31Z
publishDate 2021-01-01
publisher Elsevier
record_format Article
series Journal of the Formosan Medical Association
spelling doaj.art-927c808bd39d4637a520827fe49a07072022-12-21T22:30:15ZengElsevierJournal of the Formosan Medical Association0929-66462021-01-011201688696Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomyJing-Ren Tseng0Kai-Jie Yu1Feng-Yuan Liu2Lan-Yan Yang3Ji-Hong Hong4Tzu-Chen Yen5See-Tong Pang6Li-Jen Wang7Department of Nuclear Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, Taiwan; Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan; Corresponding author. Department of Nuclear Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), No.6, Sec.2, Jincheng Rd., Tucheng Dist., New Taipei City, 236, Taiwan.Division of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, TaiwanDepartment of Nuclear Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, TaiwanBiostatistics Unit, Clinical Trial Center, Chang Gung Memorial Hospital at Linkou, Taoyuan, TaiwanDepartment of Radiation Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; Institute for Radiological Research, Chang Gung Memorial Hospital/Chang Gung University, Linkou, Taoyuan, TaiwanDepartment of Nuclear Medicine, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, Taiwan; Department of Medical Imaging and Radiological Sciences, College of Medicine, Chang Gung University, Taoyuan, TaiwanDivision of Urology, Department of Surgery, Chang Gung Memorial Hospital at Linkou, Taoyuan, TaiwanDepartment of Medical Imaging and Intervention, New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation), New Taipei City, Taiwan; Corresponding author.Background/Purpose: We sought to compare the diagnostic performances of 68Ga-PSMA-11 PET/CT and prostate/whole-abdomen multiparametric magnetic resonance imaging (PWAmpMRI) in Taiwanese patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy. Methods: Between June 2017 and December 2018, we prospectively enrolled 34 patients. Upon review of all available clinical and imaging data, a best valuable comparator (BVC) was defined on an individual basis in the light of a consensus reached by a multidisciplinary tumor board. Diagnostic positivity was investigated in relation to the different lesion types. Results: On a patient-based analysis, 68Ga-PSMA-11 PET/CT and PWAmpMRI showed a moderate agreement (kappa coefficient = 0.62). 68Ga-PSMA-11 PET/CT identified local recurrences, regional, and non-regional lymph node metastases, and bone metastases in 15, 10, 1, and 5 patients, respectively. Conversely, PWAmpMRI detected these lesions in 26, 8, 1, and 4 patients, respectively. When the BVC was used as reference standard, the positive diagnostic rates for local recurrences, regional lymph node metastases, non-regional lymph node metastases, and bone metastases were 57.7%, 90.9%, 100%, and 100%, respectively for 68Ga-PSMA-11 PET/CT, and 100%, 72.7%, 100%, and 80% for PWAmpMRI, respectively. The use of both PWAmpMRI and 68Ga-PSMA-11 PET/CT showed a complete diagnostic yield for detecting both local recurrence and systemic failure when PSA levels reached 0.5 ng/mL. Conclusion: Due to urine radioactivity, 68Ga-PSMA-11 PET/CT performs less than PWAmpMRI on local recurrences. However, it can have a complementary diagnostic role in the detection of lymph node metastases and in identifying non-axial bone metastases beyond the PWAmpMRI scanning field.http://www.sciencedirect.com/science/article/pii/S0929664620303417Magnetic resonance imagingPositron-emission tomographyProstate cancerRobot-assisted radical prostatectomy
spellingShingle Jing-Ren Tseng
Kai-Jie Yu
Feng-Yuan Liu
Lan-Yan Yang
Ji-Hong Hong
Tzu-Chen Yen
See-Tong Pang
Li-Jen Wang
Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
Journal of the Formosan Medical Association
Magnetic resonance imaging
Positron-emission tomography
Prostate cancer
Robot-assisted radical prostatectomy
title Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
title_full Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
title_fullStr Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
title_full_unstemmed Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
title_short Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy
title_sort comparison between 68ga psma 11 pet ct and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot assisted radical prostatectomy
topic Magnetic resonance imaging
Positron-emission tomography
Prostate cancer
Robot-assisted radical prostatectomy
url http://www.sciencedirect.com/science/article/pii/S0929664620303417
work_keys_str_mv AT jingrentseng comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT kaijieyu comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT fengyuanliu comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT lanyanyang comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT jihonghong comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT tzuchenyen comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT seetongpang comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy
AT lijenwang comparisonbetween68gapsma11petctandmultiparametricmagneticresonanceimaginginpatientswithbiochemicallyrecurrentprostatecancerfollowingrobotassistedradicalprostatectomy